Skip to main content

WORK PACKAGE 3

Pain mechanisms and treatment

The aim of WORK PACKAGE 3 is to identify and define phenotypes/endotypes for pain and the association between disease activity and pain.

Work package managers

Manager

Senior researcher Ida Bos-Haugen, MD PhD

Vice director

Senior researcher Kaja K. Selmer, MD PhD

More about the projects included in or associated with WORK PACKAGE 3:

WP1 - Optimized medical interventions

MERINO

Methotrexate in the treatment of erosive hand osteoarthritis

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercise ullamco laboris nisi ut aliquip ex ea commodo consequat.
WP6 - Dechiphering long-term outcomes

NOR-DMARD

The Norwegian register for antirheumatic drugs

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercise ullamco laboris nisi ut aliquip ex ea commodo consequat.
WP3 - Pain mechanisms and management

Nor-Hand

Longitudinal observational study of people with hand osteoarthritis

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercise ullamco laboris nisi ut aliquip ex ea commodo consequat.
WP3 - Pain mechanisms and management

Rehab Benefit

Specialized rehabilitation at private rehabilitation institutions

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercise ullamco laboris nisi ut aliquip ex ea commodo consequat.
WP3 - Pain mechanisms and management

Pain following inflammatory joint diseases

To what extent are factors such as central sensitization, psychological strain, gender and systemic biomarkers associated with higher symptom strain?

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercise ullamco laboris nisi ut aliquip ex ea commodo consequat.
WP2 - PPhenotyping for personalized medicine

ULTRABIT

Longitudinal ultrasound study of patients with rheumatoid arthritis starting treatment with biological DMARD drugs

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercise ullamco laboris nisi ut aliquip ex ea commodo consequat.